Business Description
Lobe Sciences Ltd
NAICS : 541714
SIC : 3741
ISIN : CA53946V2066
Compare
Compare
Traded in other countries / regions
LOBE.CanadaLOBEF.USA6YX0.Germany IPO Date
2019-10-01Description
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.57 | |||||
| Debt-to-Equity | -1.99 | |||||
| Debt-to-EBITDA | -0.87 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -30.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year EPS without NRI Growth Rate | 41.6 | |||||
| 3-Year FCF Growth Rate | 45.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.42 | |||||
| 9-Day RSI | 46.1 | |||||
| 14-Day RSI | 46.39 | |||||
| 6-1 Month Momentum % | -3.87 | |||||
| 12-1 Month Momentum % | -0.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.04 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 217.6 | |||||
| Days Sales Outstanding | 2.74 | |||||
| Days Payable | 26873.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.1 | |||||
| Shareholder Yield % | -23.97 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.34 | |||||
| Operating Margin % | -292.43 | |||||
| Net Margin % | -303.58 | |||||
| FCF Margin % | -109.54 | |||||
| ROA % | -138.61 | |||||
| ROIC % | -125.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.97 | |||||
| EV-to-EBIT | -1.72 | |||||
| EV-to-EBITDA | -1.79 | |||||
| EV-to-Revenue | 4.67 | |||||
| EV-to-FCF | -4.43 | |||||
| Earnings Yield (Greenblatt) % | -58.14 | |||||
| FCF Yield % | -38.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LOBEF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lobe Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.723 | ||
| EPS (TTM) ($) | -0.029 | ||
| Beta | -0.05 | ||
| Volatility % | 63.06 | ||
| 14-Day RSI | 46.39 | ||
| 14-Day ATR ($) | 0.00259 | ||
| 20-Day SMA ($) | 0.013145 | ||
| 12-1 Month Momentum % | -0.67 | ||
| 52-Week Range ($) | 0.0082 - 0.0225 | ||
| Shares Outstanding (Mil) | 171.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lobe Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lobe Sciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lobe Sciences Ltd Frequently Asked Questions
What is Lobe Sciences Ltd(LOBEF)'s stock price today?
The current price of LOBEF is $0.01. The 52 week high of LOBEF is $0.02 and 52 week low is $0.01.
When is next earnings date of Lobe Sciences Ltd(LOBEF)?
The next earnings date of Lobe Sciences Ltd(LOBEF) is 2024-11-28 Est..
Does Lobe Sciences Ltd(LOBEF) pay dividends? If so, how much?
Lobe Sciences Ltd(LOBEF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers